LORICRIN and Alzheimer disease: In AD, Th2 cells secrete IL-4, IL-13 and IL-31 acting as main drivers of barrier defects by reduction of differentiation markers such as filaggrin (FLG), loricrin (LOR) and involucrin (IVL)10,11.